Outcomes of a Residential and Community-Based Co-occurring Disorders Treatment Program

We evaluated an intensive, integrated treatment program for men with serious mental illness and co-occurring substance use disorder, which incorporated several evidence-based interventions. Independent researchers rated transcripts from quality improvement interviews to examine recovery in five key domains: housing, education/employment, family relationships, mental health, and substance use. The final sample comprised 82 participants; 60 (73.2%) had left the treatment program, and 22 (26.8%) remained engaged in services of varying intensity. Mean length of stay was 18.2 months (SD = 20.1). A large proportion of participants recovered on each domain (ranging from n = 40, 48.8% on education/employment to n = 55, 67.1% on substance use). Those who remained in treatment for at least a year (n = 37, 45.1%), compared with those who left earlier (n = 45, 54.9%), were significantly more likely to be in recovery in each of the five domains. Men with long-term dual disorders can achieve clinical and functional recovery when they receive intensive, integrated, evidence-based interventions for at least 1 year.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Rent this article via DeepDyve

Similar content being viewed by others

Clinical effects and treatment outcomes of long-term compulsory in-patient treatment of treatment-resistant patients with severe mental illness and substance-use disorder

Integrated Dual Disorder Treatment Implementation in a Large State Sample

Multicomponent Co-Occurring Disorders Treatment and Wraparound Services for Individuals Experiencing Chronic Homelessness

References

• Ahrnsbrak, R., Bose, J., Hedden, S., Lipari, R., & Park-Lee, E. (2017). Key substance use and mental health indicators in the United States: results from the 2016 national survey on drug use and health. Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Google Scholar
• Baker, A. L., Hides, L., & Lubman, D. I. (2010). Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review. The Journal of Clinical Psychiatry, 71(3), 247–254. https://doi.org/10.4088/JCP.09r05119gry. ArticlePubMedGoogle Scholar
• Bruns, E. J., Kerns, S. E. U., Pullmann, M. D., Hensley, S. W., Lutterman, T., & Hoagwood, K. E. (2015). Research, data, and evidence-based treatment use in state behavioral health systems, 2001–2012. Psychiatric Services, 67(5), 496–503. https://doi.org/10.1176/appi.ps.201500014. ArticlePubMedGoogle Scholar
• Dishion, T., Forgatch, M., Chamberlain, P., & Pelham 3rd., W. E. (2016). The Oregon model of behavior family therapy: from intervention design to promoting large-scale system change. Behavior Therapy, 47(6), 812–837. https://doi.org/10.1016/j.beth.2016.02.002. ArticlePubMedPubMed CentralGoogle Scholar
• Dixon, L. (1999). Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research, 35, S93–S100. https://doi.org/10.1016/S0920-9964(98)00161-3. ArticlePubMedGoogle Scholar
• Drake, R. E., & Bond, G. R. (2010). Implementing integrated mental health and substance abuse services. Journal of Dual Diagnosis, 6(3–4), 251–262. https://doi.org/10.1080/15504263.2010.540772. ArticleGoogle Scholar
• Drake, R. E., Merrens, M. R., & Lynde, D. W. (2005). Evidence-based mental health practice: a textbook. WW Norton & Co.
• Drake, R. E., McHugo, G. J., Xie, H., Fox, M., Packard, J., & Helmstetter, B. (2006). Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin, 32(3), 464–473. https://doi.org/10.1093/schbul/sbj064. ArticlePubMedPubMed CentralGoogle Scholar
• Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 123–138. https://doi.org/10.1016/j.jsat.2007.01.011. ArticlePubMedGoogle Scholar
• Drake, R. E., Luciano, A. E., Mueser, K. T., Covell, N. H., Essock, S. M., Xie, H., & McHugo, G. J. (2016). Longitudinal course of clients with co-occurring schizophrenia-spectrum and substance use disorders in urban mental health centers: a 7-year prospective study. Schizophrenia Bulletin, 42(1), 202–211. https://doi.org/10.1093/schbul/sbv110. ArticlePubMedGoogle Scholar
• Epstein, J., Barker, P., Vorburger, M., & Murtha, C. (2004). Serious mental illness and its co-occurrence with substance use disorders, 2002. (DHHS Publication o. SMA 04-3905, Analytic Series A-24). Rockville: Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Google Scholar
• Hartz, S. M., Pato, C. N., Medeiros, H., Cavazos-Rehg, P., Sobell, J. L., Knowles, J. A., et al. (2014). Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry, 71(3), 248–254. https://doi.org/10.1001/jamapsychiatry.2013.3726. ArticlePubMedPubMed CentralGoogle Scholar
• Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37(1), 11–24. https://doi.org/10.1016/j.addbeh.2011.09.010. ArticlePubMedGoogle Scholar
• Kessler, R. C. (2004). The epidemiology of dual diagnosis. Biological Psychiatry, 56(10), 730–737. https://doi.org/10.1016/j.biopsych.2004.06.034. ArticlePubMedGoogle Scholar
• Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. The American Journal of Orthopsychiatry, 66(1), 17–31. https://doi.org/10.1037/h0080151. ArticleCASPubMedGoogle Scholar
• Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month dsm-iv disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62(6), 617–627. https://doi.org/10.1001/archpsyc.62.6.617. ArticlePubMedPubMed CentralGoogle Scholar
• Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., & Dixon, L. B. (2009). The schizophrenia patient outcomes research team (port): updated treatment recommendations 2009. Schizophrenia Bulletin, 36(1), 94–103. https://doi.org/10.1093/schbul/sbp130. ArticlePubMedPubMed CentralGoogle Scholar
• Luciano, A. E., Bryan, E. L., Carpenter-Song, E. A., Woods, M. R., Armstrong, K., & Drake, R. E. (2014). Long-term sobriety strategies for men with co-occurring disorders. Journal of Dual Diagnosis, 10(4), 212–219. https://doi.org/10.1080/15504263.2014.961884. ArticlePubMedPubMed CentralGoogle Scholar
• McGovern, M. P., Lambert-Harris, C., Gotham, H. J., Claus, R. E., & Xie, H. (2014). Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems. Administration and Policy in Mental Health and Mental Health Services Research, 41(2), 205–214. https://doi.org/10.1007/s10488-012-0449-1. ArticlePubMedGoogle Scholar
• McHugo, G. J., Drake, R. E., Whitley, R., Bond, G. R., Campbell, K., Rapp, C. A., et al. (2007). Fidelity outcomes in the national implementing evidence-based practices project. Psychiatric Services, 58(10), 1279–1284. https://doi.org/10.1176/ps.2007.58.10.1279. ArticlePubMedGoogle Scholar
• Morin, L., & Franck, N. (2017). Rehabilitation interventions to promote recovery from schizophrenia: a systematic review. Frontiers in Psychiatry, 8, 100. https://doi.org/10.3389/fpsyt.2017.00100. ArticlePubMedPubMed CentralGoogle Scholar
• Mueser, K. T., & Gingerich, S. (2013). Treatment of co-occurring psychotic and substance use disorders. Social Work in Public Health, 28(3–4), 424–439. https://doi.org/10.1080/19371918.2013.774676. ArticlePubMedGoogle Scholar
• New Freedom Commission on Mental Health. (2003). Achieving the promise: transforming mental health care in america. Final report (Pub No. SMA-03-3832). Bethesda: US Department of Health and Human Services. Google Scholar
• Noel, V. A., Woods, M. R., Routhier, J., & Drake, R. E. (2016). Planning treatment and assessing recovery in participants with dual diagnosis: preliminary evaluation of a new clinical tool. Journal of Dual Diagnosis, 12(1), 55–62. https://doi.org/10.1080/15504263.2016.1146555. ArticlePubMedGoogle Scholar
• Prochaska, J. O., Norcross, J. C., & DiClemente, C. C. (1994). Changing for good. New York: Avon Books. Google Scholar
• Reeves, W. C., Strine, T. W., Pratt, L. A., Thompson, W., Ahluwalia, I., Dhingra, S. S., et al. (2011). Mental illness surveillance among adults in the United States. Morbidity and Mortality Weekly Report: Surveillance Summaries, 60(Suppl 3), 1–29. Google Scholar
• Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (eca) study. Jama, 264(19), 2511–2518. ArticleCASGoogle Scholar
• Ridgely, M. S., Goldman, H. H., & Willenbring, M. (1990). Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophrenia Bulletin, 16(1), 123–132. https://doi.org/10.1093/schbul/16.1.123. ArticleCASPubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration. (2017). 2017 uniform reporting system (urs) output tables. Available from https://www.samhsa.gov/data/report/2017-uniform-reporting-system-urs-output-tables. Accessed 20 Aug 2018.
• Vaillant, G. E. (1995). The natural history of alcoholism revisited. Cambridge: Harvard University Press. Google Scholar
• Vandevelde, S., Vander Laenen, F., De Ruysscher, C., Bryssinck, D., De Maeyer, J., Meesen, D., & Broekaert, E. (2018). Reflections on a service user perspective in supporting persons with dual diagnosis: the case of Villa Voortman. International Journal of Mental Health and Addiction, 16(5), 1189–1192. https://doi.org/10.1007/s11469-017-9840-1. ArticleGoogle Scholar
• Walker, E. R., McGee, R. E., & Druss, B. G. (2015). Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry, 72(4), 334–341. https://doi.org/10.1001/jamapsychiatry.2014.2502. ArticlePubMedPubMed CentralGoogle Scholar
• Watson, D. P., & Rollins, A. L. (2015). The meaning of recovery from co-occurring disorder: views from consumers and staff members living and working in housing first programming. International Journal of Mental Health and Addiction, 13(5), 635–649. https://doi.org/10.1007/s11469-015-9549-y. ArticlePubMedPubMed CentralGoogle Scholar
• Woods, M. R., & Drake, R. E. (2011). Treatment of a young man with psychosis and polysubstance abuse. Journal of Dual Diagnosis, 7(3), 175–185. https://doi.org/10.1080/15504263.2011.593418. ArticleGoogle Scholar
• World Health Organization. (2009). Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization. Google Scholar
• World Health Organization. (2013). Mental health action plan 2013–2020. Geneva: WHO Document Production Services. Google Scholar

Acknowledgments

We wish to thank the staff at WestBridge for their hard work on data aggregation and verification, particularly Sarah White, who also took great care in going through records to locate missing data and helping to verify information when in question.

Author information

Authors and Affiliations

1. The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, 1 Medical Center Drive, Williamson Building #501AD, Lebanon, NH, 03756, USA Stephanie C. Acquilano
2. ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Montréal, Québec, Canada Valerie A. Noel
3. Douglas Hospital Research Centre, Montréal, Québec, Canada Valerie A. Noel
4. GateHouse Treatment, Nashua, NH, USA James Gamache
5. WestBridge Inc., Manchester, NH, USA Delia Cimpean Hendrick
6. Westat, Lebanon, NH, USA Robert E. Drake

1. Stephanie C. Acquilano